- £2.08m
- £1.90m
- £0.61m
REG - IQ-AI Limited - Imaging Biometrics granted FDA “Fast-Track”
AnnouncementREG - IQ-AI Limited - IQ-AI Announces Positive Interim Phase 1 Results
AnnouncementREG - IQ-AI Limited - Holding(s) in Company
AnnouncementREG - Stock Exch Notice - Admission to Trading - 15/11/2023
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - IQ-AI Limited - Director Dealing and Conversion of CLNs
AnnouncementREG - IQ-AI Limited - Application for Pediatric Rare Disease Designation
AnnouncementREG - IQ-AI Limited - Holding(s) in Company
AnnouncementREG - IQ-AI Limited - Update Regarding Imaging Biometrics LLC
AnnouncementREG - IQ-AI Limited - IB Letter to Shareholders
AnnouncementREG - IQ-AI Limited - Orphan Drug Status to GaM and Total Voting Rights
AnnouncementREG - IQ-AI Limited - Holding(s) in Company
AnnouncementREG - IQ-AI Limited - IQ-AI shares cease trading on the OTCQB
AnnouncementREG - IQ-AI Limited - Reduced Gadolinium Approach Validated'
AnnouncementREG - IQ-AI Limited - Update on Collaboration Agreement with Mayo Clinic
AnnouncementREG - IQ-AI Limited - IB & GE HealthCare Enter into Commercial Agreement
AnnouncementREG - IQ-AI Limited - Half-year Report
AnnouncementRCS - IQ-AI Limited - Imaging Biometrics Installs IB Nimble™ For MCW
AnnouncementREG - IQ-AI Limited - Orphan Drug Designation for GaM in Pediatric GBM
Announcement